Synthego Corporation’s CRISPR Light Control Technology Receives the 2021 Technology Innovation Award by Lucintel

Dallas, October 07, 2021 -- Based on recent research on the Gene Editing market, Lucintel is pleased to announce Synthego Corporation’s CRISPR Light Control Technology as the recipient of the “2021 Technology Innovation Award in the Gene Editing Market”. Lucintel chose Synthego Corporation for this award because of its cutting-edge technology, that helps in standardizing predictable gene editing across a variety of disease areas and also possess the potential to optimize on-target editing events and the ability to spatially pattern cells in-vitro.

Synthego Corporation’s CRISPR Light Control Technology is a new class of guide molecules, CRISPRoff™, a synthetic sgRNA, which fragments in response to light, enabling precise temporal and spatial control of double-strand breaks created during gene editing. It does not require additional engineering steps or changes to nucleases, thus it can be fitted easily within existing CRISPR gene editing workflows without any modifications.

Synthego Corporation’s CRISPRoff™ can be chemically tuned to respond to different wavelengths of light, which also allows for multiplexed genome engineering. Thus, it ensures safe and controlled genome editing for the development of therapeutics. It is also considered as a critical tool that is being used in the CRISPR research.

Lucintel’s awards in innovation and industry excellence recognize outstanding achievements and latest endeavors by companies in various industries, identifying the most successful, innovative, and forward-thinking companies and products in business today. Lucintel awards are based on systematic and detailed research on the relevant markets to identify and recognize the most successful recent innovations. These initiatives enable companies to demonstrate high levels of industry impact and benefits to end users. To know more contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com

About Lucintel

Lucintel, a premier market research and Management Consulting firm based in Dallas, Texas, has served over 1,000 clients for over 20 years. With our in-depth analysis and sage advice, Lucintel offers solutions for your growth through game changing ideas and analysis of robust markets and unmet needs. Lucintel has been quoted in esteemed publications, including The Wall Street Journal, ZACKS, and The Financial Times. For further information, visit www.lucintel.com.

About Synthego Corporation

Synthego Corporation is based in United States and is a genome engineering company, which enables the acceleration of life science research and development in the pursuit of improved human health. Synthego Corporation’s CRISPR Light Control Technology is considered as a breakthrough in advancing gene editing to new level of precision, as shown in www.synthego.com/press/crisproff-gene-editing. Company focuses on developing reliable benchmarks for assay qualification and community norms that can increase reproducibility. For further information, www.synthego.com/

Contact:

Brandon Fitzgerald

Lucintel

Dallas, Texas, USA

Email: brandon.fitzgerald@lucintel.com

Tel. 972.636.5056

Cell: 303.775.0751

Enable GingerCannot connect to Ginger Check your internet connection

or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger×Enable GingerCannot connect to Ginger Check your internet connection

or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger×